Reuters logo
BRIEF-Galapagos buys drug discovery firm Cangenix
January 15, 2013 / 6:36 AM / 5 years ago

BRIEF-Galapagos buys drug discovery firm Cangenix

BRUSSELS, Jan 15 (Reuters) - Galapagos NV : * Galapagos buys Cangenix, a structure-based drug discovery company * Says will pay a total cash consideration of 1 million pounds, with a further

440,000 pounds potential earn out payment

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below